Join Evelyn Pyper, MPH, as she discusses how PicnicHealth is using real-world data to transform neurodegeneration research.

Evelyn Pyper, MPH discusses how a patient-centered approach to real-world data collection and evidence generation can transform research in neurodegeneration. Neurodegenerative diseases often affect both motor and cognitive function, produce emotional and social changes, and require significant caregiver support, all while stretching across a fragmented healthcare ecosystem. Participatory research that directly obtains patient consent, empowers patients, and simplifies the task of linking multiple data sources, can lead to a more comprehensive capture of medical histories. This presentation briefly explores ways in which patient-centered research can improve understanding of disease diagnoses, symptomatology, and progression.

Key Topics Include:

  • The value of patient consent and patient-generated data in neurodegenerative disease research
  • The importance of using unstructured data to construct a complete picture of patient health
  • Real-world examples of how patient-centered data can improve our understanding of patient subpopulations
Click to watch the webinar recording. To view the presentation full screen simply click the square icon located in the bottom-right corner of the video-viewer.


To retrieve a PDF copy of the presentation, click on the link below the slide player. From this page, click on the “Download” link to retrieve the file.


Senior Evidence Strategy Manager
Life Sciences Partnerships

Evelyn Pyper is Senior Evidence Strategy Manager at PicnicHealth, a patient-centric real-world data company. Her career in RWE spans the public and private sector, and regional and global markets - most recently as Assoc. Director, Market Access at J&J GPH. Evelyn is completing her DPhil in Evidence-Based Health Care at the University of Oxford.

Production Partner


PicnicHealth is giving patients unprecedented access to and control of their medical records, and with their consent, the opportunity to participate in research. Using industry leading machine learning, we deliver patient-level real-world data at scale to life sciences companies, unlocking the most complete view of real-world patient journeys.

Additional Content From

Additional Content From HealthEconomics.Com

Related Content

Integrating Patient Engagement and Trainee Development in Pre-Clinical Research

Integrating Patient Engagement and Trainee Development in Pre-Clinical Research

Christopher Perry, PhD discusses how his laboratory aims to discover mechanisms by which metabolic dysfunction causes muscle weakness and apply these findings to develop new therapies for muscle disorders. Homira Osman, PhD provides a particular focus on leveraging scientific findings for practice and policy and linking trainees with patient communities.